NM
Nelli Morgulchik
Investor at Hummingbird Ventures
Tel Aviv-Yafo, Tel Aviv District
Overview
Nelli Morgulchik is an Investor at Hummingbird Ventures focusing on early-stage biotech startups, with a background in strategy, partnerships, and venture development. With a Master's degree from Imperial College London and experience at Pioneer Group and Hertility, Nelli's career highlights include leading projects at Imperial Consulting Group and co-founding SenseBlock.
She invests in Series A and seed stage startups within sectors such as drug delivery, diagnostics, and digital health, showcasing expertise in healthcare consulting and market research.
Work Experience
Advisor & Consultant
2022 - Current
Advisor & consultant supporting bio- & health-tech startups in go-to-market strategy, business development and fundraising.
Investor
2024 - 2024
invested in one-of-a-kind biotech founders across the globe - pre-seed to series A 🧬
Accelerator Lead
2022 - 2024
turned ideas into startups - one accelerator at a time
Strategy & Partnerships Associate
2021 - 2022
blueprinted strategies, sparked biz dev, and charmed investors—fuelling women's health innovation
Analyst
2020 - 2021
consulted big pharma to get drugs from pipeline to patient
CBPartners is a strategy consulting firm focusing on strategic issues for multinational pharma, biopharm, med device companies & governments
Co-Founder
2018 - 2019
learned a lot through trial and error about building IP-driven capital intensive startups